High-growth D2C brand preparing for significant institutional capital infusion from global private equity and hedge funds.
Contextual Background
Preliminary vendor due diligence revealed critical gaps in statutory filings, unregistered core trademark IP, and a disorganized capitalization table that was misaligned with historical regulatory records. These gaps threatened to trigger significant indemnity holdbacks or valuation de-rating during the final investment window.
Strategic Complexity
The mandate required navigating the complex environment of Indian corporate and labor law to transform a legacy operational structure into a "transaction-ready" institutional asset. The primary challenge was the multi-dimensional regularisation of years of informal governance. This involved resolving historical share issuance anomalies under the Companies Act, where past filings (PAS-3 and MGT-7) were inconsistent with the physical register of members. Simultaneously, we managed the high-risk remediation of labour law backlogs, particularly regarding Provident Fund (PF), ESI, and Gratuity contributions, which are often the primary triggers for buyer "escrow" demands. The complexity was further amplified by the need to secure a fragmented IP portfolio—including trademarks and copyrights—that had been historically held in individual founder names rather than the corporate entity, creating a "chain of title" break that would have stalled any institutional due diligence.
Key regulatory, commercial, and execution issues addressed during the mandate.
CELA Mandate
Acting as Pre-Investment Remediation Counsel, CELA functioned as the architect of the company’s "Transaction Readiness" from inception. We moved beyond drafting filings to become strategic designers of the company’s governance logic. Our role was to provide the "regulatory foresight" required to navigate the complex Companies Act and labour landscapes, ensuring that the company’s contractual and statutory stack was resilient to the most rigorous institutional scrutiny.
Execution Strategy
01
Cap Table Regularisation & ROC Recovery
We orchestrated a comprehensive audit of the company’s capitalization history, resolving complex share issuance anomalies and regularizing overdue PAS-3 and SH-7 filings through compounding and condonation processes. This ensured that the capitalization table was in absolute alignment with ROC records, providing a clean "primary" and "secondary" trail for the incoming institutional investors.
02
Labour Law Remediation & Immunity
We led the regularisation of historical labour compliance backlogs, utilizing statutory amnesty and immunity schemes where available to minimize penalty exposure. This involved overhauling the company’s PF/ESI registration framework and standardizing employment contracts to include robust "Confidentiality and IP Assignment" clauses, effectively neutralizing the risk of legacy labour litigation or "successor liability" claims.
03
IP Fortress & Chain-of-Title Securing
We conducted a "sweep-up" of the company’s intellectual property, fast-tracking trademark registrations across multiple critical classes and securing formal IP Assignment Agreements from founders and external consultants. This ensured that all core assets—including brand names, software code, and marketing content—were legally vested in the parent company, removing any "IP leakage" risks for the buy-side diligence team.
04
Contract Standardisation & Vendor Governance
To replace the client’s historical reliance on informal vendor arrangements, we implemented a modular Master Services Agreement (MSA) stack. This standardized the company’s core commercial contracts, ensuring that key supplier and partner agreements contained institutional-grade indemnities, termination rights, and data-protection protocols required by global private equity standards.
Quantifiable Outcomes
100%
Warranties Cleared
Buy-side DD cleared without a single adverse finding.
Zero
Holdbacks
Historical compliance defects successfully regularized.
Secured
IP Portfolio
Full legal vesting in the corporate parent entity.
The company successfully cleared institutional buy-side due diligence, securing a significant capital infusion without material indemnity holdbacks tied to historical compliance. By providing a clean compliance record and a well-organized data room, we helped the brand protect valuation and move faster into its next phase of expansion.
Strategic Impact
This corporate case study shows that in the Indian transaction landscape, compliance hygiene is not a cost center—it is a primary determinant of valuation and deal velocity.
